Published in Lab Business Week, July 16th, 2006
The financing was led by New Enterprise Associates (NEA) with additional investments by OrbiMed Advisors and Red Abbey Venture Partners and a significant equity participation by Human Genome Sciences, Inc. (HGSI). Founded by former senior executives of HGS, CoGenesys is advancing a broad pipeline of improved, long-acting biopharmaceuticals developed to address unmet medical needs across a broad spectrum of therapeutic areas.
Craig A. Rosen, PhD, CoGenesys'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.